Table 5

Medical consumption per patient (in Euro) during 6 months

Apnoea/hypopnoea index ≥30Apnoea/hypopnoea index <30
CPAPWaiting for CPAPp‐value*CPAPWaiting for CPAPp‐value*
Patients n50583231
General practitioner visits35.1 (25.9–44.2)30.7 (21.3–40.1)0.2428.4 (18.5–38.4)34.5 (18.5–50.4)0.71
Specialist visits18.7 (8.0–29.4)20.4 (8.0–32.9)0.9137.1 (20.3–54)25.8 (10.2–41.4)0.32
Drugs233.6 (170.6–296.5)174.3 (112.8–235.7)0.06257.1 (158.6–355.6)198.1 (108.9–287.3)0.43
Complementary tests40.9 (25.4–56.4)36.27 (16.8–55.7)0.2164.8 (31.1–98.4)38.2 (22.4–54.0)0.77
Subtotal328.3 (252.9–403.6)262.8 (176.9–348.7)0.06387.6 (257.3–517.9)296.6 (198.2–395.1)0.47
CPAP treatment222.601×10−4222.501×10−4
Total555.9 (475.5–626.2)262.8 (176.9–348.7)1×10−4610.1 (479.8–740.4)296.6 (198.2–395.0)1×10−4
  • Data are presented as mean (95% confidence interval) unless otherwise stated

  • CPAP: continuous positive airway pressure

  • *: Wilcoxon test comparing the change over time (difference) observed in each group (continuous positive airway pressure (CPAP) versus waiting for CPAP)